A decade-long personal struggle with chronic pelvic pain has prompted co-founder Emilia Lewicka to establish Heliax, a Wrocław-based healthtech startup designed to streamline the diagnostic process for patients experiencing similar challenges.
The Problem Heliax Aims to Solve
Patients seeking diagnosis for chronic pelvic pain often endure years of uncertainty, navigating complex medical systems and accumulating substantial costs. The typical diagnostic journey in Poland can exceed 50,000 PLN, consuming considerable time and financial resources while patients move between specialists without clear answers.
Lewicka’s personal experience with this grueling process informed her decision to channel that frustration into developing a commercial solution. Rather than accepting the status quo of lengthy diagnostic pathways, she co-founded Heliax to create an alternative approach that addresses both the timeline and expense associated with identifying pelvic pain conditions.
The Vitabloom Solution
The startup’s primary offering, Vitabloom, functions as a digital tool intended to compress the diagnostic timeline significantly. By providing patients with a structured pathway through the diagnostic process, the solution seeks to reduce the years of uncertainty that characterize conventional approaches to pelvic pain diagnosis.
The platform appears designed to bridge gaps in the current healthcare system, where patients often struggle to find relevant specialists or receive coordinated care across multiple medical disciplines. Through Vitabloom, Heliax aims to create clarity in what is typically a confusing and fragmented patient journey.
Addressing a Significant Healthcare Gap
Chronic pelvic pain remains a widespread health concern affecting a substantial portion of the population, yet it remains underdiagnosed and often poorly understood within general medical practice. The condition encompasses various underlying causes, requiring specialist knowledge that general practitioners frequently lack. This knowledge gap contributes significantly to diagnostic delays.
By developing a healthtech solution specifically targeting this condition, Heliax positions itself within a growing category of European startups focused on improving diagnostic pathways and patient outcomes. The company’s approach combines digital health technology with domain-specific expertise, reflecting broader trends in European healthtech innovation.
Polish Healthtech Landscape
Heliax’s establishment in Wrocław contributes to Poland’s emerging reputation as a center for healthtech innovation. The country has seen increasing activity in digital health startups addressing unmet medical needs, particularly in areas where traditional healthcare systems face capacity or knowledge constraints.
The founding of Heliax demonstrates how personal experiences with healthcare inefficiencies can catalyze entrepreneurial solutions. As European healthcare systems face mounting pressures around access and efficiency, startups tackling specific diagnostic challenges represent one avenue through which patients and entrepreneurs are driving systemic improvements.
The success of initiatives like Heliax may ultimately influence how healthcare providers across Europe approach complex diagnostic challenges, particularly for conditions that currently require extensive specialist consultation and extended timelines.